Sequential changes in the cyclic nucleotide levels and cyclic nucleotide phosphodiesterase activities during development ofMyxococcus xanthus

Published Erratum

J Ho et al. Curr Microbiol. 1980 Jul.

. 1980 Jul;3(4):202.

doi: 10.1007/BF02602448.

No abstract available

Erratum for

Sequential changes in the cyclic nucleotide levels and cyclic nucleotide phosphodiesterase activities during development ofmyxococcus xanthus.
Ho J, McCurdy HD. Ho J, et al. Curr Microbiol. 1980 Jul;3(4):197-202. doi: 10.1007/BF02602447. Curr Microbiol. 1980. PMID: 27520761
Multiple cyclic nucleotide phosphodiesterases in human trabecular meshwork cells.
Zhou L, Thompson WJ, Potter DE. Zhou L, et al. Invest Ophthalmol Vis Sci. 1999 Jul;40(8):1745-52. Invest Ophthalmol Vis Sci. 1999. PMID: 10393044
Enzymatic characteristics of two novel Myxococcus xanthus enzymes, PdeA and PdeB, displaying 3',5'- and 2',3'-cAMP phosphodiesterase, and phosphatase activities.
Kimura Y, Okazaki N, Takegawa K. Kimura Y, et al. FEBS Lett. 2009 Jan 22;583(2):443-8. doi: 10.1016/j.febslet.2008.12.044. Epub 2008 Dec 27. FEBS Lett. 2009. PMID: 19114044
Amantadine: an antiparkinsonian agent inhibits bovine brain 60 kDa calmodulin-dependent cyclic nucleotide phosphodiesterase isozyme.
Kakkar R, Raju RV, Rajput AH, Sharma RK. Kakkar R, et al. Brain Res. 1997 Feb 28;749(2):290-4. doi: 10.1016/S0006-8993(96)01318-2. Brain Res. 1997. PMID: 9138729
Differential activation and inhibition of the multiple forms of cyclic nucleotide phosphodiesterase.
Weiss B. Weiss B. Adv Cyclic Nucleotide Res. 1975;5:195-211. Adv Cyclic Nucleotide Res. 1975. PMID: 165666 Review.